FindTrial
Sign In

Comparison of 1- day and 2-days prophylactic antimicrobial administration for inhibiting surgical site infection (SSI) in Holmium Laser Enucleation of the prostate (HoLEP).

Comparison of 1- day and 2-days prophylactic antimicrobial administration for inhibiting surgical site infection (SSI) in Holmium Laser Enucleation of the prostate (HoLEP). - Comparison of 1- day and 2-days prophylactic antimicrobial administration for inhibiting SSI in HoLEP.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027955
Enrollment
400
Registered
2017-07-01
Start date
2017-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostate hyperplasia

Interventions

1-day cefazoin i.v. every 12 hours 2-days cefazoin i.v. every 12 hours

Sponsors

Kobe Univerity
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Those patients who undergo HoLEP

Exclusion criteria

Exclusion criteria: Those patients who do not agree with this study as a participant.

Design outcomes

Primary

MeasureTime frame
Rate of SSI occurence—

Countries

Japan

Contacts

Public ContactKatsumi Shigemura

Kobe University Urology

katsumi@med.kobe-u.ac.jp078-382-6155

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026